Skip to main content
. 2016 Oct 6;7(46):74678–74685. doi: 10.18632/oncotarget.12492

Table 2. Heparanase staining in metastatic melanoma.

Site of metastases No of patients (%) Negative or weak (0/+1) Strong (+2)
Skin 14 (20) 5 (36) 9 (64)
Brain 21 (30) 12 (57) 9 (43)
Lung 9 (13) 7 (78) 2 (22)
Lymph nodes 15 (22) 9 (53) 7 (47)
Other 10 (14) 5 (50) 5 (50)
Total 69 37 32